Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
申请人:——
公开号:US20030078270A1
公开(公告)日:2003-04-24
Novel compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification, and certain previously known compounds have been discovered to act as inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. The compound can also be used in co-treatment with retinoids.
1
Substituted tetralins I: Synthesis and Analgesic Activities of Some 2-Aminotetralins
作者:Arnold R. Martin、Anilkumar P. Parulkar、David J. Gusseck、Leray J. Anderson、Gary L. Grunewald、Allen I. White
DOI:10.1002/jps.2600580312
日期:1969.3
Exploitation of Rh(<scp>i</scp>)–Rh(<scp>iii</scp>) cycles in enantioselective C–C bond cleavages: access to β-tetralones and benzobicyclo[2.2.2]octanones
作者:Laetitia Souillart、Nicolai Cramer
DOI:10.1039/c3sc52753k
日期:——
Rhodium(I)-catalyzed β-carbon eliminations of tert-cyclobutanols followed by oxidative addition give benzorhoda(III)cyclopentenes. These key intermediates trigger intramolecular CâH arylations leading to β-tetralones with quaternary stereogenic centers in excellent enantioselectivity. The versatility of the rhoda(III)cyclic species is further shown in formal intramolecular [4+2]-cycloadditions providing access to benzobicyclo[2.2.2]octanones.